It has been reported that AS-IV may alleviate peroxisome proliferator-activated receptor γ (PPARγ)/ axis-mediated neuroinflammation and relieve depression-like behaviors in chronic restraint stress-induced and LPS-induced mice by up-regulating PPARγ expression. Here, PPARG is linked to depressive disorder.